BioCentury
ARTICLE | Company News

YM acquiring Eximias

April 14, 2006 12:04 AM UTC

YM (TSX:YM; YMI) said that it will acquire fellow cancer company Eximias (Berwyn, Penn.) in a stock and cash deal expected to close in early May. YM did not disclose the value of the deal but did say that Eximias shareholders will receive at least $25 million in YM stock. Eximias, which currently has about $30 million in cash, will be renamed YM BioSciences USA Inc. and serve as YM's U.S. headquarters. ...